Skip to main content

Animations

MJFF Publications

3601 - 3610 of 6310 Results
Title
Year
  • Year
  • 2025
  • 2019
  • 2015
  • 2020
  • 2018
  • 2018
  • 2010
  • 2021
  • 2015
  • 2018
  • Summary Details
    OPEN
    Title: Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-025-02859-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982
    Citation Count: 65
  • Summary Details
    OPEN
    Title: A Novel Lead Design for Modulation and Sensing of Deep Brain Structures
    Journal Name: IEEE Transactions on Biomedical Engineering
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/tbme.2015.2492921
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Role of data measurement characteristics in the accurate detection of Parkinson’s disease symptoms using wearable sensors
    Journal Name: Journal of NeuroEngineering and Rehabilitation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12984-020-00684-4
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005
    Citation Count: 17
  • Summary Details
    OPEN
    Title: PP1 Phosphatase Complexes: Undruggable No Longer
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, elsevier-specific: oa user license
    DOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2010.05.009
    Citation Count: 215
  • Summary Details
    OPEN
    Title: CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awab103
    Citation Count: 245
  • Summary Details
    OPEN
    Title: Stiripentol for the treatment of super-refractory status epilepticus
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ane.12403
    Citation Count: 42
  • Summary Details
    OPEN
    Title: β2‐adrenoreceptor medications and risk of Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25341
    Citation Count: 72
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.